体外脓毒症模型中炎症小体激活可重现脓毒症患者单核细胞分布宽度增加
本研究利用细菌内毒素(LPS)建立体外脓毒症模型,通过显微镜和标准临床血液分析仪测量单核细胞分布宽度(MDW),探讨炎症小体激活与单核细胞大小变化的关系。野生型THP1细胞经LPS处理后细胞面积显著增加(207 μm2 [159-400 μm2] vs 160 μm2 [134-198 μm2];p < 0.001),分布宽度也显著增加(198 vs 55 μm2;p < 0.0001),且MDW增加与炎症小体激活(IL-1β释放)及显微镜下见到的大的肿胀焦亡细胞相关。这些效应在炎症小体成分(ASC、caspase-1、gasdermin-D)敲除细胞中均被阻断。全血样本经同样处理也显示IL-1β释放和MDW增加(中位数24.7 U [22.2-27.2 U] vs 16.3 U [15.1-17.6 U];p = 0.008)。结论提示脓毒症患者MDW增加可在体外重现,焦亡性细胞肿胀可能是MDW变化的基础。
要点
- 野生型THP1细胞经LPS处理后细胞面积显著增加(207 μm2 [159-400 μm2] vs 160 μm2 [134-198 μm2];p < 0.001),分布宽度增加(198 vs 55 μm2;p < 0.0001)。
- 全血样本经LPS处理后MDW显著升高(中位数24.7 U [22.2-27.2 U] vs 16.3 U [15.1-17.6 U];p = 0.008),使用Beckman-Coulter Unicel DxH900分析仪测量。
- MDW增加与炎症小体激活标志物IL-1β释放及显微镜下大的肿胀焦亡细胞相关。
- CRISPR/Cas9敲除炎症小体关键成分(ASC、caspase-1、gasdermin-D)可阻断LPS诱导的细胞面积增加、MDW升高和IL-1β释放。
- 外周血单个核细胞分离后经LPS处理,显微镜下也可见大的焦亡细胞,与IL-1β释放相关。
适用人群与场景
- 健康成年志愿者及培养的人单核细胞细胞(野生型及炎症小体成分敲除后)
- 体外脓毒症模型,使用细菌内毒素(LPS)处理标本
研究设计与关键结果
- 研究类型:体外实验研究,使用LPS处理野生型及CRISPR/Cas9敲除炎症小体成分(ASC、caspase-1、gasdermin-D)的THP1细胞和全血样本。
- 野生型THP1细胞经LPS处理后,显微镜下细胞面积显著增加(207 μm2 [159-400 μm2] vs 160 μm2 [134-198 μm2];p < 0.001),分布宽度增加(198 vs 55 μm2;p < 0.0001)。
- MDW增加与炎症小体激活(IL-1β释放)及显微镜下大的肿胀焦亡细胞相关;这些效应在炎症小体敲除细胞中被阻断。
- 全血样本经LPS处理后IL-1β释放和MDW增加(中位数24.7 U [22.2-27.2 U] vs 16.3 U [15.1-17.6 U];p = 0.008),使用Beckman-Coulter Unicel DxH900分析仪测量。
- 外周血单个核细胞分离后经LPS处理,显微镜下可见大的焦亡细胞,与IL-1β释放相关。
证据类型、等级与局限
- 证据类型:体外实验研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脓毒症患者MDW增加可在体外脓毒症模型中重现,并可被CRISPR/Cas9技术灭活炎症小体所阻断;这些发现提示焦亡性细胞肿胀是脓毒症患者MDW变化的基础,并将MDW与脓毒症炎症级联的早期事件联系起来。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Increased monocyte distribution width (MDW) has recently been shown to be a reliable indicator of early sepsis detection. This study therefore sought to determine if inflammasome activation can be linked to monocyte size changes in sepsis.
DESIGN: An in vitro sepsis model using bacterial endotoxin (lipopolysaccharide [LPS]) to study the effect of inflammasome activation on monocyte cell size distribution by microscopy and MDW measurements using a standard clinical hematology analyzer.
SETTING: University research laboratory.
SUBJECTS: Healthy adult volunteers and cultured human monocyte cells in wild-type state and after clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 knockout of key inflammasome components (apoptosis-associated speck-like protein containing a caspase recruitment domain, caspase-1, gasdermin-D).
INTERVENTIONS: In vitro treatment of specimens with bacterial LPS.
MEASUREMENTS AND MAIN RESULTS: Wild-type THP1 cells demonstrated a significant increase in cell area (207 μm2 [159-400 μm2] vs 160 μm2 [134-198 μm2]; p < 0.001) and distribution width (198 vs 55 μm2; p < 0.0001) by microscopy following treatment with LPS. Increased MDW correlated with inflammasome activation as demonstrated by release of interleukin (IL)-1β and with the presence of large distended pyroptotic cells by microscopy. All of these effects were blocked in the inflammasome knockout cells. Whole blood samples treated similarly also demonstrated IL-1β release and increased MDW (median 24.7 U [22.2-27.2 U] vs 16.3 U [15.1-17.6 U]; p = 0.008) as measured using the Beckman-Coulter Unicel DxH900 analyzer. When peripheral blood mononuclear cells were isolated prior to treatment with LPS, microscopy confirmed the presence of large pyroptotic cells correlating to IL-1β release in the human subject samples as well.
CONCLUSIONS: The increased MDW seen in patients with sepsis can be reproduced in an in vitro sepsis model and blocked using clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 technology to inactivate the inflammasome. These findings suggest that pyroptotic cellular swelling underlies changes in MDW in septic patients and connect MDW to early events in the inflammatory cascade of sepsis.
参考来源
- Eisinger GJ, Osman W, Prather ER, et al. Inflammasome Activation in an In Vitro Sepsis Model Recapitulates Increased Monocyte Distribution Width Seen in Patients With Sepsis. Crit Care Explor. 2022. PMID: 35128458. doi:10.1097/CCE.0000000000000631
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。